RS

Rajiv Sharma

Active Director Director DIN 08416652
DIN 08416652 First appointment Apr 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Rajiv Sharma

Data last updated:

Rajiv Sharma is a Director at Beactive Pharmaceuticals Private Limited (since 2019). The company operates in Healthcare. Beactive Pharmaceuticals Private Limited reported revenue of ₹36.6 Lakh (FY 2024).

DIN 08416652
Primary Designation Director
Industry Healthcare
First Appointment 09 Apr 2019
Oldest Company Age 7 yrs
Largest company Beactive Pharmaceuticals Private Limited · ₹36.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Apr 20192019₹36.6 Lakh (FY 2024)Active

Board colleagues of Rajiv Sharma

Directorship timeline

Open interactive timeline →
Beactive Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajiv Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Sharma

Rajiv Sharma currently holds 1 directorship: Beactive Pharmaceuticals Private Limited (Director, since 09 Apr 2019, revenue ₹36.6 Lakh (FY 2024)).

Rajiv Sharma was first appointed on 09 Apr 2019 as Director at Beactive Pharmaceuticals Private Limited.

The current boards of Rajiv Sharma's companies include Rahul Sharma (Beactive Pharmaceuticals Private Limited), Shubham Sharma (Beactive Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available